Entera Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	69	78	17	21	81	20
Market Cap Growth	-24.20%	351.66%	-17.80%	-74.05%	308.59%	-23.76%
Enterprise Value	62	71	10	7	54	13
Last Close Price	1.58	2.12	0.60	0.73	2.81	1.08
PS Ratio	566.04	431.41	-	156.95	141.91	54.33
PB Ratio	4.74	9.66	1.67	1.79	3.59	2.64
P/TBV Ratio	4.61	9.66	1.67	1.79	3.59	2.64
EV/Sales Ratio	498.60	394.91	-	51.05	94.51	35.56
Debt / Equity Ratio	0.01	0.03	0.04	0.01	0.01	0.06
Net Debt / Equity Ratio	-0.55	-1.04	-1.02	-1.04	-1.09	-1.09
Net Debt / EBITDA Ratio	0.78	0.88	1.20	0.91	2.02	0.74
Net Debt / FCF Ratio	1.18	1.23	1.45	0.97	2.71	0.77
Asset Turnover	0.01	0.02	-	0.01	0.03	0.03
Quick Ratio	5.46	7.47	10.10	9.36	7.93	4.81
Current Ratio	10.83	7.63	10.32	9.58	8.01	4.95
Return on Equity (ROE)	-99.43%	-103.34%	-80.30%	-76.17%	-81.04%	-115.46%
Return on Assets (ROA)	-53.80%	-56.64%	-44.65%	-43.06%	-42.77%	-52.83%
Return on Capital Employed (ROCE)	-68.40%	-116.70%	-83.30%	-114.30%	-53.50%	-141.70%
Earnings Yield	-15.36%	-12.22%	-51.42%	-62.15%	-15.04%	-56.56%
FCF Yield	-10.10%	-8.73%	-42.38%	-59.65%	-11.21%	-53.50%
Buyback Yield / Dilution	-25.17%	-29.79%	-0.69%	-10.23%	-41.90%	-51.62%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q